Hider, S L <br/><br/>
Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA?  [electronic resource] 

 -  Annals of the rheumatic diseases  Jun 2003 
 - 591; author reply 591-2 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.62.6.591  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--blood<br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--genetics<br/>Drug Resistance--genetics<br/>Humans<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Statistics, Nonparametric